One study has reported that resistance to anti-BRAF, anti-MEK, and combination treatments was mediated by formation of the eIF4F translation initiation complex in melanoma, colon, and thyroid cancer cell lines (11). This evidence concerns the gene EIF4G1 and melanoma.